GeneDx Holdings Corp. Pre-Tax Income
GeneDx Holdings Corp. (WGS) reported Pre-Tax Income of -$18.26 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Income Statement › Pre-tax Income
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest · last filed 2026-08-03
- GeneDx Holdings Corp. income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2026-06-30 was -$18.26M, a 272.85% decline year-over-year.
- GeneDx Holdings Corp. income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2026-03-31 was -$62.42M.
- GeneDx Holdings Corp. income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2025-12-31 was -$18.23M, a 436.72% decline year-over-year.
- GeneDx Holdings Corp. income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2025-09-30 was -$7.39M.
- GeneDx Holdings Corp. income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2025 was -$21.14M.
- GeneDx Holdings Corp. income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2024 was -$52.63M.
- GeneDx Holdings Corp. income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2023 was -$176.69M.
- GeneDx Holdings Corp. income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2022 was -$598.03M.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 3 month | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 3 month as first filed | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 6 month | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 6 month as first filed | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 9 month | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 9 month as first filed | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$18.26M 10-Q · filed 2026-08-03 | -$80.68M 10-Q · filed 2026-08-03 | -$98.91M derived: sum of 3 quarters · filed 2026-08-03 | -$106.30M derived: sum of 4 quarters · filed 2026-08-03 | |||
| 2026-03-31 | -$62.42M 10-Q · filed 2026-05-04 | -$80.65M derived: sum of 2 quarters · filed 2026-05-04 | -$88.04M derived: sum of 3 quarters · filed 2026-05-04 | -$77.47M derived: sum of 4 quarters · filed 2026-08-03 | |||
| 2025-12-31 | -$18.23M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | -$25.62M derived: sum of 2 quarters · filed 2026-02-23 | -$15.05M derived: sum of 3 quarters · filed 2026-08-03 | -$21.14M 10-K · filed 2026-02-23 | |||
| 2025-09-30 | -$7.39M 10-Q · filed 2025-10-28 | $3.17M derived: sum of 2 quarters · filed 2026-08-03 | -$2.91M 10-Q · filed 2025-10-28 | $2.51M derived: sum of 4 quarters · filed 2026-08-03 | |||
| 2025-06-30 | $10.56M 10-Q · filed 2026-08-03 | $4.48M 10-Q · filed 2026-08-03 | $9.89M derived: sum of 3 quarters · filed 2026-08-03 | $1.54M derived: sum of 4 quarters · filed 2026-08-03 | |||
| 2025-03-31 | -$6.08M 10-Q · filed 2026-05-04 | -$668.00K derived: sum of 2 quarters · filed 2026-05-04 | -$9.03M derived: sum of 3 quarters · filed 2026-05-04 | -$38.39M derived: sum of 4 quarters · filed 2026-05-04 | |||
| 2024-12-31 | $5.41M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | -$2.94M derived: sum of 2 quarters · filed 2026-02-23 | -$32.31M derived: sum of 3 quarters · filed 2026-02-23 | -$52.63M 10-K · filed 2026-02-23 | |||
| 2024-09-30 | -$8.36M 10-Q · filed 2025-10-28 | -$37.72M derived: sum of 2 quarters · filed 2025-10-28 | -$58.04M 10-Q · filed 2025-10-28 | -$84.23M derived: sum of 4 quarters · filed 2026-02-23 | |||
| 2024-06-30 | -$29.36M 10-Q · filed 2025-07-29 | -$49.68M 10-Q · filed 2025-07-29 | -$75.87M derived: sum of 3 quarters · filed 2026-02-23 | -$118.33M derived: sum of 4 quarters · filed 2026-02-23 | |||
| 2024-03-31 | -$20.32M 10-Q · filed 2025-04-30 | -$46.51M derived: sum of 2 quarters · filed 2026-02-23 | -$88.96M derived: sum of 3 quarters · filed 2026-02-23 | -$135.88M derived: sum of 4 quarters · filed 2026-02-23 | |||
| 2023-12-31 | -$26.18M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | -$68.64M derived: sum of 2 quarters · filed 2026-02-23 | -$115.56M derived: sum of 3 quarters · filed 2026-02-23 | -$176.69M 10-K · filed 2026-02-23 | |||
| 2023-09-30 | -$42.46M 10-Q · filed 2024-10-29 | -$89.37M derived: sum of 2 quarters · filed 2024-10-29 | -$150.51M 10-Q · filed 2024-10-29 | -$459.18M derived: sum of 4 quarters · filed 2024-10-29 | |||
| 2023-06-30 | -$46.91M 10-Q · filed 2024-07-30 | -$108.05M 10-Q · filed 2024-07-30 | -$416.72M derived: sum of 3 quarters · filed 2024-07-30 | -$494.37M derived: sum of 4 quarters · filed 2024-07-30 | |||
| 2023-03-31 | -$61.14M 10-Q · filed 2024-04-29 | -$369.81M derived: sum of 2 quarters · filed 2024-04-29 | -$447.45M derived: sum of 3 quarters · filed 2024-04-29 | -$582.27M derived: sum of 4 quarters · filed 2024-04-29 | |||
| 2022-12-31 | -$308.67M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-23 | -$386.32M derived: sum of 2 quarters · filed 2024-02-23 | -$521.14M derived: sum of 3 quarters · filed 2024-02-23 | -$598.03M 10-K · filed 2024-02-23 | |||
| 2022-09-30 | -$77.65M 10-Q · filed 2023-11-03 | -$212.47M derived: sum of 2 quarters · filed 2023-11-03 | -$289.36M 10-Q · filed 2023-11-03 | -$329.55M derived: sum of 4 quarters · filed 2023-11-03 | |||
| 2022-06-30 | -$134.82M 10-Q · filed 2023-08-08 | -$211.72M 10-Q · filed 2023-08-08 | -$251.90M derived: sum of 3 quarters · filed 2023-08-08 | -$219.17M derived: sum of 4 quarters · filed 2023-08-08 | |||
| 2022-03-31 | -$76.90M 10-Q · filed 2023-05-09 | -$117.08M derived: sum of 2 quarters · filed 2023-05-09 | -$84.35M derived: sum of 3 quarters · filed 2023-05-09 | -$130.51M derived: sum of 4 quarters · filed 2023-05-09 | |||
| 2021-12-31 | -$40.19M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | -$7.45M derived: sum of 2 quarters · filed 2023-03-16 | -$53.62M derived: sum of 3 quarters · filed 2023-03-16 | -$245.39M 10-K · filed 2023-03-16 | |||
| 2021-09-30 | $32.73M 10-Q · filed 2022-11-14 | $31.39M 10-Q · filed 2021-11-15 | -$13.43M derived: sum of 2 quarters · filed 2022-11-14 | -$205.21M 10-Q · filed 2022-11-14 | -$204.96M 10-Q · filed 2021-11-15 | -$245.06M derived: sum of 4 quarters · filed 2022-11-14 | |
| 2021-06-30 | -$46.16M 10-Q · filed 2022-08-15 | $13.01M 10-Q · filed 2021-07-21 | -$237.94M 10-Q · filed 2022-08-15 | -$45.46M 10-Q · filed 2021-07-21 | -$277.79M derived: sum of 3 quarters · filed 2022-08-15 | -$334.40M derived: sum of 4 quarters · filed 2022-08-15 | |
| 2021-03-31 | -$191.78M 10-Q · filed 2022-05-12 | -$58.47M 10-Q · filed 2021-05-24 | -$231.63M derived: sum of 2 quarters · filed 2022-05-12 | -$288.24M derived: sum of 3 quarters · filed 2022-05-12 | |||
| 2020-12-31 | -$39.85M derived: 10-K/A 6 month − 10-Q 3 month · filed 2021-05-05 | -$39.91M 10-K/A · filed 2021-05-05 | -$192.24K 10-K · filed 2021-03-30 | -$241.34M 10-K · filed 2023-03-16 | |||
| 2020-09-30 | -$56.92K 10-Q · filed 2020-11-16 | -$115.66M 10-Q · filed 2021-11-15 | |||||
| 2019-12-31 | -$29.70M 10-K · filed 2022-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |